KHAI TRINH: Open Payments
NPI 1194400929 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,271 in 112 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $1,740 · 2025 $2,271
Food & beverage: $2,271
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $420 |
| Corcept Therapeutics | 10 | $231 |
| Lilly USA, LLC | 11 | $216 |
| ABBVIE INC. | 18 | $200 |
| Phathom Pharmaceuticals, Inc. | 1 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $138 |
| Ardelyx, Inc. | 5 | $108 |
| Novo Nordisk Inc | 5 | $96 |
| Amgen Inc. | 4 | $81 |
| Gilead Sciences, Inc. | 3 | $75 |
Products named: FARXIGA, Korlym, AIRSUPRA, MOUNJARO, VOQUEZNA, Linzess, JARDIANCE, IBSRELA.
Industry payments across CA — which companies pay providers there.
